• Amvis posted net sales of JPY 38.29 billion, up 5.3%, for the first nine months ended June 30, 2026.
• Operating profit fell 22.9% to JPY 3.62 billion; profit attributable to owners of parent slipped 17.1% to JPY 2.49 billion.
• Ishinkan segment sales rose 3.9% to JPY 37.39 billion; segment profit dropped 33.8% to JPY 3.02 billion.
• Comprehensive Medical Support sales more than doubled to JPY 897 million; segment profit more than doubled to JPY 599 million.
• Kept full-year forecast unchanged, targeting net sales of JPY 51.7 billion and operating profit of JPY 3.8 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amvis Holdings Inc. published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.